Get started
Award

32571707

Funded outputs count: 7
Funder award ID: 32571707
OpenAlex ID: G1415000930
Targeting senescence-mediated immune resistance for enhanced tumor immunotherapy
2026 · Siyu Chen, Jingyi Su, et al. · Journal of Cancer Metastasis and Treatment
PDF
Molecular design and delivery of extracellular and membrane protein degradation chimeras
2026 · Shutong Lin, Huiling Zhou, et al. · Advanced Drug Delivery Reviews
PDF
Targeting multidimensional nociceptor-tumor interactions to mitigate immune evasion of cancer
2026 · Aojia Jin, Jiaxing Pan, et al. · 中国科学通报：英文版
POLY-Senolytic nanoplatform for tumor-specific eradication of senescent tumor cells and mitigation of radiotherapy-induced immune resistance of cancer
2026 · Yi Lai, Shunan Zhang, et al. · Nature Communications
Glycoengineered Host-Guest Nanoparticles Potentiate Alzheimer’s Disease Therapy via Lesion-Specific Modulation of Tau Pathology
2026 · Yi Lai, Jiaxing Pan, et al. · Journal of the American Chemical Society · 2
A senescent tumor cell-derived nanovesicle directly primes splenic T cells to potentiate cancer radiotherapy
2026 · Jiaxing Pan, Shun Zhang, et al. · Cell Reports Medicine · 3
Hypoxia-responsive paclitaxel prodrugs: linker evaluation and NIR-triggered self-amplifying photodynamic-chemotherapy nanoplatform
2026 · Furou Lv, Jianxin Rong, et al. · Biomaterials · 8
Year
Topic